|
Originally published In Press as doi:10.1194/jlr.R800033-JLR200 on November 14, 2008
Journal of Lipid Research, Vol. 50, S237-S242, April 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology
Phospholipase A2 structure/function, mechanism, and signaling1
John E. Burke and
Edward A. Dennis2
Departments of Chemistry and Biochemistry, and Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093-0601
1 Guest editor for this article was Martha K. Cathcart, Lerner Research Institute, the Cleveland Clinic.
This work was supported by National Institutes of Health Grant GM20501 (E.A.D).
Published, JLR Papers in Press, November 14, 2008.
2 To whom correspondence should be addressed. e-mail: edennis{at}ucsd.edu
ABSTRACT
Tremendous advances in understanding the structure and function of the superfamily of phospholipase A2 (PLA2) enzymes has occurred in the twenty-first century. The superfamily includes 15 groups comprising four main types including the secreted sPLA2, cytosolic cPLA2, calcium-independent iPLA2, and platelet activating factor (PAF) acetyl hydrolase/oxidized lipid lipoprotein associated (Lp)PLA2. We review herein our current understanding of the structure and interaction with substrate phospholipids, which resides in membranes for a representative of each of these main types of PLA2. We will also briefly review the development of inhibitors of these enzymes and their roles in lipid signaling.
Supplementary key words lipid signaling phospholipids arachidonic acid

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Webpages:
JLR 50th Anniversary Collections
Anniversary Collection::Signaling
This article has been cited by other articles:

|
 |

|
 |
 
E. Ramadan, A. O. Rosa, L. Chang, M. Chen, S. I. Rapoport, and M. Basselin
Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid
J. Lipid Res.,
August 1, 2010;
51(8):
2334 - 2340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Song, M. Wohltmann, S. Bao, J. H. Ladenson, C. F. Semenkovich, and J. Turk
Mice deficient in Group VIB phospholipase A2 (iPLA2{gamma}) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet
Am J Physiol Endocrinol Metab,
June 1, 2010;
298(6):
E1097 - E1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Basselin, H. W. Kim, M. Chen, K. Ma, S. I. Rapoport, R. C. Murphy, and S. E. Farias
Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation
J. Lipid Res.,
May 1, 2010;
51(5):
1049 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Granata, A. Frattini, S. Loffredo, R. I. Staiano, A. Petraroli, D. Ribatti, R. Oslund, M. H. Gelb, G. Lambeau, G. Marone, et al.
Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2
J. Immunol.,
May 1, 2010;
184(9):
5232 - 5241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. Vanden Berghe
The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis
Sci. Signal.,
March 30, 2010;
3(115):
re4 - re4.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Menter, R. L. Schilsky, and R. N. DuBois
Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward
Clin. Cancer Res.,
March 1, 2010;
16(5):
1384 - 1390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wada, T. Yasuda, I. Miura, K. Watabe, C. Sawa, H. Kamijuku, S. Kojo, M. Taniguchi, I. Nishino, S. Wakana, et al.
Establishment of an Improved Mouse Model for Infantile Neuroaxonal Dystrophy That Shows Early Disease Onset and Bears a Point Mutation in Pla2g6
Am. J. Pathol.,
December 1, 2009;
175(6):
2257 - 2263.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|